← Back to Search

Behavioral Intervention

ADEPT Intervention for Vaccine Hesitancy (ADEPT Trial)

N/A

Waitlist Available

Led By Lavanya Vasudevan, PhD, MPH

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months post birth

Awards & highlights

ADEPT Trial Summary

This trial seeks to increase parental confidence in childhood vaccinations by providing expectant parents with accurate information during pregnancy.

Who is the study for?

This trial is for expectant parents with a single pregnancy, no prior live births, and no known fetal issues. They must be in the early third trimester and getting prenatal care at a participating practice. Those at risk for preterm birth cannot join.Check my eligibility

What is being tested?

The study tests if giving factual vaccine information to expectant parents during pregnancy can increase their confidence in childhood vaccines and ensure their child gets vaccinated on time.See study design

What are the potential side effects?

Since this intervention involves providing information rather than a medical treatment, there are no direct physical side effects expected from participating in this trial.

ADEPT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months post birth

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months post birth

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months post birth for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of children receiving timely vaccinations

Secondary outcome measures

Change in Vaccine Hesitancy

ADEPT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ADEPTExperimental Treatment1 Intervention

Individuals receiving prenatal care at a practice that was randomized to deliver the ADEPT intervention.

Group II: Standard of CareActive Control1 Intervention

Individuals receiving prenatal care at a practice that was randomized to deliver the standard of care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,559,803 Total Patients Enrolled

Lavanya Vasudevan, PhD, MPHPrincipal InvestigatorEmory University

Media Library

ADEPT (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05795855 — N/A

Vaccine Refusal Research Study Groups: ADEPT, Standard of Care

Vaccine Refusal Clinical Trial 2023: ADEPT Highlights & Side Effects. Trial Name: NCT05795855 — N/A

ADEPT (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05795855 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers actively seeking participants for this experiment?

"This research is no longer recruiting participants, as indicated by the clinicaltrials.gov webpage; it was originally posted on November 1st 2023 and last edited on March 21st 2023. However, there are 4 similar studies presently accepting volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Adaptive Prenatal Intervention to Increase Childhood Vaccinations

Lavanya Vasudevan 2024. "An Adaptive Prenatal Intervention to Increase Childhood Vaccinations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05795855.